Long-term engraftment and clonal dominance of donor-derived del(20q) hematopoietic cells after allogeneic stem cell transplantation

Authors:

Abstract
During the 7 years of posttransplantation follow-up, we analyzed donor cell engraftment in myeloid and lymphoid compartments of both blood and bone marrow using conventional cytogenetics, FISH, and variable number tandem repeats (VNTRs). Chimerism analysis by VNTRs confirmed 100% donor hematopoiesis in lymphoid and myeloid lineages by day 34 after transplantation, which has remained stable to date. Shortly after transplantation, at day 158, approximately 10% of granulocytes and monocytes in the blood carried the del(20q) abnormality; however, this population increased to represent 56% to 73% of blood myeloid cells by 3 and 7 years, respectively, after transplantation (Table 1). In addition, even though the del(20q) was not detectable in T cells (CD3+) or B cells (CD19+) at the time of engraftment, 16% of T cells and 26% of B cells were determined by FISH to be part of the abnormal clone at 7 years after transplantation.